Home / Brand archive
19 reported ongoing
20 records in this archive. Latest source date Feb 13, 2026.
FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.
Class IIReported ongoing
Distribution: Nationwide in the USA.
Out of specification for dissolution.
Class IIReported ongoing
Distribution: Nationwide in the USA
Failed Content Uniformity Specifications
Class IIReported ongoing
Distribution: U.S. Nationwide
Presence of a foreign substance.
Class IIReported ongoing
Distribution: USA Nationwide
Presence of a foreign substance.
Class IIReported ongoing
Distribution: USA Nationwide
Failed Impurity/Degradation Specifications
Class IIIReported ongoing
Distribution: Nationwide in the USA
Failed Impurity/Degradation Specifications
Class IIIReported ongoing
Distribution: Nationwide in the USA
Presence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200 mg capsules
Class IIReported ongoing
Distribution: Nationwide in the USA
Failed Dissolution Specifications
Class IIReported ongoing
Distribution: Nationwide USA
Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9% (specification of NLT 95.0% NMT 105%)
Class IIReported ongoing
Distribution: USA Nationwide
Out of Specification for Dissolution
Class IIReported ongoing
Distribution: Nationwide in the USA
LABELING: LABEL MIX-UP
Class IIIReported ongoing
Distribution: Nationwide within the United States
LABELING: LABEL MIX-UP
Class IIIReported ongoing
Distribution: Nationwide within the United States
Failed Dissolution Specifications
Class IIReported ongoing
Distribution: Nationwide USA
CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.
Class IIReported ongoing
Distribution: USA Nationwide
CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.
Class IIReported ongoing
Distribution: USA Nationwide
CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.
Class IIReported ongoing
Distribution: USA Nationwide
Labeling: Label Mix-Up
Class IIReported ongoing
Distribution: Nationwide within the United States
Labeling: Label Mix-Up
Class IIReported ongoing
Distribution: Nationwide within the United States
Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.
Class IReported terminated
Distribution: US Nationwide.
These examples come from this result page and are not a ranking of every recall reason.
This archive contains 20 records, including 19 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product.
Compare the product, firm and lot, date, model or serial identifiers with the notice. Use the label-check guide if you need help locating an identifier.
A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall.
This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. Check source coverage and the agency's current notices.
Use monthly archives or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page.